Introduction
Status epilepticus (SE) affects Ͼ100,000 people each year in the United States and carries a 27% mortality with high morbidity in survivors, and little progress has been made in understanding the pathophysiology or improving treatment in the last 40 years (DeLorenzo et al., 1996) . We do not understand why, in SE, seizures tend to become self-sustaining or why benzodiazepines are effective early in the course of SE but may sustain a 20-fold loss of potency by 30 min and fail to arrest SE by 45 min (Kapur and Macdonald, 1997; Mazarati et al., 1998b; Treiman et al., 1998) . Indeed, the rapid evolution of seizure activity and timedependent loss of pharmacological response is one of the reasons for a lack of therapeutic progress (Treiman, 1995; Treiman et al., 1998) . In this study, we found a functional loss of postsynaptic GABA A receptors and a marked internalization of GABA A receptor subunits by 1 h of SE, associated with a pronounced loss of GABAergic synaptic inhibition. These results may explain, in part, the transition from single seizures to pharmacoresistant self-sustaining SE.
Materials and Methods

Electrophysiological recordings: whole-cell patch clamp
Four-to seven-week-old male Wistar rats (Simonsen Laboratories, Gilroy, CA) received lithium (3 mEq/kg, i.p.; the previous night) and methylscopolamine (1 mg/kg, s.c.) 30 min before either pilocarpine (40 mg/ kg, i.p.) (Sigma, St. Louis, MO) or normal saline. All animal studies were approved by the Institutional Animal Care and Use Committee. After ϳ1 h from the onset of stage 5 seizures (Racine, 1972) , animals were anesthetized with halothane and then decapitated, and the brains were placed in ice-cold artificial CSF (ACSF) containing the following (in mM): 126 NaCl, 2.5 KCl, 2 CaCl 2 , 2 MgCl 2 , 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 10 D-glucose, 1 pyruvate, 0.3 ascorbic acid, and 3 kynurenic acid (Sigma), pH 7.3. Coronal sections (350 m) (Leica VT1000S; Leica, Bannockburn, IL) were held in a chamber at room temperature bubbled with 95% O 2 and 5% CO 2 until transfer to a chamber perfused at 1.5 ml/min with 33-35°C ACSF, in which recordings from somata of visualized neurons were made using an Axoclamp-2B amplifier (Molecular Devices, Foster City, CA). While blocking indirect circuitry effects with 1 M tetrodotoxin (Calbiochem, La Jolla, CA), some slices from lithium control animals were incubated in 40 mg/L pilocarpine for ϳ1 h to control for a direct pharmacological effect of pilocarpine. Electrode solutions for miniature IPSC (mIPSC) recordings contained the following (in mM): 140 CsCl, 4 NaCl, 2 MgCl 2 , 10 HEPES, 0.05 EGTA, and 2 Mg-ATP (Sigma) (holding potential, Ϫ70 mV). For polysynaptic-evoked IPSC recordings, the electrode solution was composed of the following (in mM): 130 Cs-gluconate, 10 CsCl, 2 MgCl 2 , 10 HEPES, 0.05 EGTA, 5 tetraethylammonium-Cl, and 2 Mg-ATP. The holding potential for evoked events was 0 mV with bipolar electrode stimulation (MicroProbe, Gaithersburg, MD) via the perforant path (pulses, 40 -100 V; 0.1-0.15 ms). Electrode solutions were titrated to pH 7.25 with an osmolarity of 280 -300 mOsm. Borosilicate electrodes were pulled (Sutter Instruments, Novato, CA) for a resistance of 4 -6 M⍀, and recordings with series resistance changes exceeding 50% were excluded.
Solutions and drugs
ACSF for mIPSC recordings contained 1 M tetrodotoxin and 3 mM kynurenic acid. ACSF for tonic GABA A currents contained 10 M 1-[2[[(diphenylmethylene)imino]oxy]ethyl]-1,2,5,6-tetrahydro-3-pyridinecarboxylic acid hydrochloride (NO711) with 1 M GABA, and 2-(3-carboxypropyl)-3-amino-6-(4-methoxyphenyl)-pyridazinium bromide (SR95531) was applied directly to the recording chamber by pipette for a final concentration of 100 M (Sigma). For select mIPSC recordings, diazepam (10 mg/L; Abbott Laboratories, Chicago, IL) was added to the perfusate. It was difficult to detect differences in tonic currents between SE and control cells without the addition of inhibitors of GABA uptake. For select experiments, higher concentrations of GABA (Յ100 M) were added to the perfusate. No drugs were added to the ACSF for evoked recordings.
Data analysis
After 3 kHz low-pass filtering with 20 kHz digitizing (Digidata 1200; Molecular Devices), event detection and analysis [e.g., peak amplitude, rise-time, and area-under-the-curve (AUC)] software was generously provided by I. Mody (University of California, Los Angeles, Los Angeles, CA). Analysis of tonic current mean and variance used 40 -50 epochs of 100 ms (devoid of IPSCs) sampled every 200 ms. A Student's t test was used to assess statistical significance.
Computer modeling
Math modeling of measurable physiology was to characterize GABA A receptor kinetic properties, postsynaptic numbers, amount and duration of exposure to cleft GABA, and receptor conductance. The modeling used personal programs written for MatLab (MathWorks, Natick, MA). mIPSCs with absolute peak amplitudes exceeding 100 pA were excluded.
For channels with open probability, P open , the binomial distribution for the population of channels at a synapse generating mIPSCs has the following mean current ( I): (Zar, 1999) , where N is the number of postsynaptic receptors per synapse, and i is the open channel current. These equations were adapted to allow variability in the number of postsynaptic receptors for the individual mIPSCs of a cell. In view of the bimodal amplitude distribution of mIPSCs (see Fig. 3C ), we assumed that the number of receptors per single synapse for control and SE cells (Table 1) corresponded with the distribution peak for the subgroup of smaller amplitude mIPSCs. P open varies depending on [GABA] . Model parameters for a seven-state GABA A receptor (Table 1) and for the peak and exponential decay of cleft [GABA] determine P open (probability of the two open states) at the synapse. These parameters that determine P open and those for N and i were optimized using Equations 1 and 2 to fit the measured mean ( I) and SD () of mIPSCs from individual cells. The assumption of a uniform current ( i) for synaptic receptors is not unreasonable, because single conductance states primarily characterize the synaptic, ␥2 subunit-containing receptors (Brickley et al., 1999; Lorez et al., 2000) . The choice of the seven-state receptor model (Table 1) was based on single-channel and outside-out patch recordings, suggesting at least two open states (Jones and Westbrook, 1995; Haas and Macdonald, 1999) and slow (desens 1 ) and fast (desens 2 ) desensitized states (Overstreet et al., 2000) . The proportion of receptors in fast and slow desensitized states depends on the concentration of GABA (Overstreet et al., 2000) , suggesting that a rate constant dependent on [GABA] (such as the path between bound 1 and bound 2 ) intervenes between the two desensitized states.
For tonic currents, P open is determined by extracellular [GABA] , and the number of receptors ( N) is now per cell, not per synapse. Substituting Equation 1 into Equation 2 determines the following parabolic equation:
allowing N and i determination from optimized fits of tonic current SD versus mean plots (see Fig. 5B ). 
Numerical methods
mIPSCs. P open is determined by the GABA A receptor kinetic parameters (Table 1 ) and varies over the course and thereby determines the shape of an mIPSC (based on the transient effect of quantal release on the two binding kinetic parameters that are dependent on cleft [GABA] ). The number of postsynaptic receptors at a particular synapse and current ( i) through the individual receptors are constant for single mIPSCs and will not affect shape but will, at any given P open , determine the amplitude and relationship between mean ( I) and SD () of mIPSCs (as defined by Eq. 3). Simultaneous fitting the mean and SD of mIPSC traces adds necessary constraint for the determination of receptor numbers and current ( i). Assuming a random (Markov) process for fluctuations between the openings and closings of a channel, model mIPSCs were generated by matrix multiplication of A (where A is 7 ϫ 7, the particular value of the matrix indexed by j and k, A jk , is the probability that a receptor in state k will transition to state j during a specified time increment of iteration) by x n (7 ϫ 1; containing the probability of each state at the current time), thereby generating the time-updated probability vector, x n ϩ 1 , to be substituted for x n in subsequent iterations (A ϫ x n ϭ x n ϩ 1 ). P open is the sum of the probabilities from each of the two open states of x n . The time increment per iteration was 0.01 ms, with successive iterations through a total of 20 ms representing a single trial. For each trial, the values for P open at each time point of the trial and the values for i and N (constant for all time points of the trial) were used to generate model traces for the mean and SD of mIPSCs (applying modifications of Eqs. 1 and 2) for comparison with the experimental traces. The errors between model and data were minimized across successive trials using a simplex algorithm (Lagarias et al., 1998) .
The general strategy for modeling mIPSCs was to make initial estimates of i and N values by optimizing the variables of Equation 3 to fit variance versus mean plots for mIPSCs. Next, estimates for synaptic GABA A receptor kinetic parameters and cleft [GABA] were obtained by methods independent of i and N, which involved fitting only the shape/ time course of the mean and SD of mIPSCs. Allowing free-scaled normalization of the model amplitude to match the actual mIPSC amplitude permits removal of i and N as parameters, because i and N are fixed across the time course of an mIPSC and, hence, will not affect its shape. Finally, a complete model fit the mean and SD of mIPSCs (including amplitudes) with free parameters for GABA A receptor kinetics, cleft [GABA] , and i and N values together using the initial estimates obtained by the earlier two steps as starting points.
Tonic currents. No dynamic change in P open occurs because extracellular [GABA] is stable (unlike synaptic vesicular GABA release). For given [GABA] , x equil (7 ϫ 1; representing the equilibrium probability of each state, including the two open states that determine P open ) is determined by solution of the equilibrium equation A equil ϫ x equil ϭ 0 (where A equil is 7 ϫ 7; the particular value indexed along row j and column k of the matrix is the rate of transition from state k to state j). The equilibrium solution (x equil ) characterizes each of the probabilities of the seven receptor states that occur for a balance to exist between the rates entering and exiting each state (with zero net change in the probability of any state).
Immunocytochemistry
Serial formaldehyde-fixed 40 m coronal sections were incubated overnight in mouse anti-␤2/␤3 (or ␥2) GABA A subunit antiserum (5 g/ml; Chemicon, Temecula, CA) and rabbit anti-synaptophysin antiserum (5 g/ml; Zymed, San Francisco, CA). The sections were incubated for 1 h in FITC-labeled goat anti-rabbit IgG (1:200; Jackson ImmunoResearch, West Grove, PA) and 3-cyano coumarin (Cy3)-labeled donkey antimouse IgG (1:500; Jackson ImmunoResearch) diluted in PBS containing 1% goat serum, horse serum, and 0.3% Triton X-100. For quantification of immunofluorescent receptors, a Z-series of optical images through control and SE hippocampi was acquired at 100ϫ with a confocal cellscanning microscope (Scanalytics, Fairfax, VA) and processed using Image Pro Lab Spectrum software (Media Cybernetics, Silver Spring, MD). Immunoreactive receptor puncta were defined as discrete points along the neuron and dendrite with fluorescence intensity at least twice the background staining. Colocalization was determined by examination of the overlaid synaptophysin and receptor-stained images, in which the percentage overlap referred to the ratio of colocalized puncta over the total number of subunit puncta. We counted all ␤2/␤3 subunitimmunoreactive cell bodies (average of 21 per section in the dentate gyrus, 18 in CA1) and 20 proximal dendrites (25 m in length per section) in four sections per animal. In control hippocampi, ␤2/␤3 subunit immunoreactivity distributed predominantly to the neuronal surface, and few ␤2/␤3 subunit-immunoreactive neurons had more than five endosome-like structures per cell body. Cell bodies with Ͼ15 ␤2/␤3 subunit-immunoreactive endosome-like structures were considered to display subunit internalization. Alternatively, GABA A receptor-positive neurons for anti-␤2/␤3 (or ␥2) were manually outlined, and MetaMorph software (Universal Imaging, West Chester, PA) used fluorescent intensity ratios to measure the number of internalized relative to total GABA A subunit-immunoreactive puncta for the neuron. Accurate ␥2 subunit-LI puncta counts for dentate granule cells was difficult with this methodology based on soma outlines, because ␥2 subunit-LI density on the soma is lower than dendrites in these cells. A Student's t test was used to determine statistical significance. Data are expressed as the number of overlaps per soma and dendrite.
Results
SE causes relocation of GABA A receptor subunits from synapses to the cell interior
In granule and pyramidal cells from control hippocampi, immunoreactivity against the ␤2/␤3 subunits of GABA A receptors (red pseudocolor) localizes to discrete puncta, which outline the cell membrane, and frequently colocalizes with the (green) presynaptic marker synaptophysin-like immunoreactivity (LI), giving these overlaps a yellow color (Fig. 1) . After 1 h of SE, much of this ␤2/␤3 subunit-LI relocates to the cell interior, which is surrounded by the synaptophysin-LI (Fig. 1 , right, bottom). In hippocampal granule cells, the proportion of ␤2/␤3 subunit-LI, which overlaps synaptophysin-LI, is reduced from 43 Ϯ 10% in controls to 13 Ϯ 4% in SE ( p Ͻ 0.001; all data as mean Ϯ SD; n ϭ 3 animals per group). The absolute number of overlaps between synaptophysin-LI and ␤2/␤3 subunit-LI on granule cells decreases from 9 Ϯ 1 on the somatic surface of controls to 3 Ϯ 1 with SE and from 10 Ϯ 2 for the 25 m proximal dendrites of controls to 3 Ϯ 2 with SE ( p Ͻ 0.001; n ϭ 3 animals per group). In the hilus, the number of overlaps is decreased by 69 Ϯ 19% in somata (72 Ϯ 20% for dendrites) during SE, and CA1 pyramidal neurons show similar reductions (CA1 soma, 65 Ϯ 15%; dendrite, 70 Ϯ 18%). Using fluorescence intensity, the ratio of internal over total puncta for ␤2/␤3 subunit-LI increases from 0.09 Ϯ 0.03 in granule cells of controls (0.15 Ϯ 0.08 for hilar cells) to 0.82 Ϯ 0.09 during SE (0.85 Ϯ 0.05 for hilar cells; p Ͻ 0.001). By a separate method, the number of cells displaying ␤2/␤3 subunit-LI in the cell interior (defined as having Ͼ15 endosomelike puncta per cell interior) increases from 9.7 Ϯ 0.6% of control granule cells to 71 Ϯ 5% after SE, and CA1 pyramids show a similar change (7.3 Ϯ 2.3% in controls; 70 Ϯ 3% in SE; p Ͻ 0.001). These changes are not seen when seizures are prevented by injecting atropine with the pilocarpine (data not shown). Internal relocation of ␤2/␤3 subunit-LI is also observed in SE induced by intrahippocampal injection of neurokinin B or by perforant path stimulation (data not shown). At the same time, immunoreactivity for the NR1 subunit of NMDA receptors moves in the opposite direction from cytoplasmic sites to the cell surface with an increase in the number of overlaps with synaptophysin (D.E. Naylor, H. Liu, and C.G. Wasterlain, unpublished observations), suggesting that the direction of trafficking during SE is type specific for receptors and not a general phenomenon. Both the GABA A and NMDA changes would be expected to increase excitability in the midst of seizures and thus appear maladaptive.
Because we and others have observed a rapid decrease in benzodiazepine potency during SE in several animal models (Kapur and Macdonald, 1997; Mazarati et al., 1998b) , we studied the ␥2 subunit, which contributes to benzodiazepine binding (Gunther et al., 1995; Saxena and Macdonald, 1996) and associates with the AP2 adaptin-clathrin complex involved with endocytosis (Connolly et al., 1999; Kittler et al., 2000) . After 1 h of lithiumpilocarpine SE, overlaps between the ␥2 subunit and synaptophysin are reduced from 8.3 Ϯ 0.9 (soma) and 10 Ϯ 0.6 (proximal (left) and SE (right) stained with an antibody against GABA A ␤2/␤3 subunits (red, top) and an antibody against the presynaptic marker synaptophysin (green, middle). Overlaps between presynaptic synaptophysin and postsynaptic GABA A subunit appear yellow (bottom). Note that fewer GABA A subunit puncta colocalize with synaptophysin with greater internalization of the red receptor subunits relative to the green synaptophysin outline during SE (right, bottom), suggesting trafficking of GABA A subunits. sg, Stratum granulosum; h, hilus.
dendrites) in granule cell controls to 2 Ϯ 0.6 (soma) and 3 Ϯ 0.6 (proximal dendrites) with SE ( p Ͻ 0.001; n ϭ 3 animals per group), and the proportion of cells at the edge of the granule cell layer with Ͼ15 internal ␥2 subunit-LI increases from 0.19 Ϯ 0.08 in controls to 0.86 Ϯ 0.04 with SE ( p Ͻ 0.001) (Fig. 2) . Thus, relocation from synapses to the cell interior of at least two subunits, including one associated with benzodiazepine sensitivity, occurs during SE and may contribute to the development of benzodiazepine pharmacoresistance.
A decrease in mIPSC amplitude suggests a loss of postsynaptic GABA A receptors during SE We used hippocampal slices obtained from animals in lithiumpilocarpine SE for 1 h to examine whether the internal location of ␤2/␤3 and ␥2 subunits reflects a decrease in the number of functional postsynaptic GABA A receptors. mIPSCs recorded from dentate gyrus granule cells in slices from SE animals decreased peak amplitude to 73% of controls (Ϫ38.8 Ϯ 9.2 pA for SE vs Ϫ53.2 Ϯ 13.4 pA for controls; all data as mean Ϯ SD; p Ͻ 0.001; n ϭ 76) and decreased the AUC to 84% of controls (Ϫ268 Ϯ 53 pA⅐ms for SE vs Ϫ320 Ϯ 83 pA⅐ms for controls). The weighteddecay time (AUC/peak amplitude) increased to 116% of controls (6.58 Ϯ 1.27 ms for SE vs 5.67 Ϯ 0.87 ms for controls; p Ͻ 0.001) (Fig. 3A) . Slowing of the 10 -90% rise time (0.38 Ϯ 0.09 ms for SE vs 0.33 Ϯ 0.05 ms for controls; p Ͻ 0.001) and a decrease of mIPSC frequency (2.16 Ϯ 1.35 Hz for SE vs 2.77 Ϯ 1.39 Hz for controls; p Ͻ 0.001) also occur with SE. mIPSCs recorded in SE slices within 2 h of decapitation show a greater amplitude decrease (to 62% of controls; Ϫ31.5 Ϯ 6.1 pA for SE vs Ϫ51.0 Ϯ 17.0 pA for controls; p Ͻ 0.001; n ϭ 19) and weighted-increase (to 122% of controls; 7.35 Ϯ 1.56 ms for SE vs 6.03 Ϯ 1.02 ms for controls; p Ͻ 0.001), suggesting recovery during the slice incubation. No significant difference of peak amplitude, AUC, or decay time is observed between lithium control slices and lithium control slices incubated in 40 mg/L pilocarpine and 1 M tetrodotoxin (n ϭ 24), suggesting that the mIPSC differences that we observed with the lithium-pilocarpine model of SE are attributable to SE and not a lithium and/or pilocarpine pharmacological effect.
To explore benzodiazepine responsiveness after SE, we recorded mIPSCs in hippocampal slices from control and SE animals while washing in high concentrations of diazepam (10 mg/ L). After diazepam, a prolongation of mIPSC weighted-decay time (to 120 Ϯ 19% of pretreatment for SE, p Ͻ 0.001, paired t test, n ϭ 13 vs to 117 Ϯ 10% of pretreatment for controls, p Ͻ 0.001, paired t test, n ϭ 10) with no increase in mIPSC peak Table 1 for model values). C, Histogram for peak amplitudes of individual mIPSC events recorded from a control (left) and an SE (right) granule cell with the superimposed predicted distribution (filled circles) from model fits of B.
amplitude contributes to an increase in mIPSC AUC in dentate granule cells. Despite no significant difference noted with the diazepam effect between cells from SE and control slices, the AUC after diazepam exposure in SE slices still remains 14 Ϯ 21% less than the AUC from control cells before diazepam treatment and 20 Ϯ 20% less than the AUC from control cells after diazepam treatment ( p Ͻ 0.01). This is because of the smaller initial AUC of mIPSCs after SE compared with controls and suggests an inability of the benzodiazepine to fully restore losses of synaptic inhibition resulting from SE.
To analyze the results, synaptic modeling of GABA A receptors (see Materials and Methods, Computer modeling) provides optimized fits to the mean and SD of mIPSCs from control and SE animals and effectively matches the features and peak amplitude distributions of mIPSCs (Fig. 3 B, C) . The basic assumptions of the synaptic model are as follows: (1) and receptor channel open probability (see Materials and Methods, Computer modeling); (3) vesicle release of the transmitter can be modeled as a pulse with exponential decay; and (4) mIPSCs represent the sum of the individual postsynaptic receptor current responses. The results of the model suggest a reduction in postsynaptic receptor number from 36 Ϯ 11 per synapse in controls (n ϭ 11; consistent with anatomical studies) (Nusser et al., 1998a) to 18 Ϯ 4 per synapse in slices obtained after 1 h of SE (n ϭ 14; p Ͻ 0.001) ( Table 1) .
We suspect that the lower mIPSC frequency that we observed in SE slices is essentially a consequence of the amplitude reduction of mIPSCs during SE (Fig. 3C) , which significantly degrades the detection of mIPSC events from baseline noise (supplemental Fig. 1 , available at www.jneurosci.org as supplemental material). A contribution from loss of synapses and/or presynaptic effects reducing vesicle release cannot be excluded.
SE causes alterations in synaptic GABA A receptor kinetics
The prolongation of mIPSC decay time observed with SE indicates intrinsic changes with the kinetics of GABA A receptor properties and/or with the kinetics of GABA exposure in the synaptic cleft. To distinguish these factors, we tabulated the results across cells (Table 1 ) for the optimized model fits of the mIPSC mean and SD traces obtained from control and SE slices (Fig. 3B) . Model-predicted changes in GABA A receptor kinetics include a decrease in the unbinding rate of GABA from the receptor (as reflected by a lowering of K off from 288 Ϯ 15 s Ϫ1 in controls to 214 Ϯ 51 s Ϫ1 with SE; p Ͻ 0.001) ( Table 1 ). The predicted, very brief, presence of GABA in the synaptic cleft [transmitter decay of 52 Ϯ 12 s for controls; similar to estimates (Destexhe and Sejnowski, 1995; Clements, 1996) including ultrafast GABA exposure (Pytel et al., 2003) ] increases during SE (107 Ϯ 51 s for SE; p Ͻ 0.001) (Fig. 4 , top trace) and is associated with an increase of the mIPSC peak GABA A receptor open probability (P open max from 0.30 Ϯ 0.01 to 0.45 Ϯ 0.07 during SE; p Ͻ 0.001). According to our model, the increase in GABA in the synaptic cleft during SE contributes to GABA A receptors rapidly entering into the longlasting desensitized states described in excised patches (Jones and Westbrook, 1995; Overstreet et al., 2000) (Fig. 4, bottom trace) . In addition, a slight left shift of the model-predicted doseresponse curve for postsynaptic GABA A receptors (Fig. 5C ) occurs with SE (also noted with dissociated granule cells) (Kapur and Macdonald, 1997) . During SE, we found no significant change of GABA A receptor channel conductance compared with controls (estimated at ϳ38 pS at 34°C). This estimate is larger than measurements of 30 pS with single-channel recordings at room temperature (Bormann, 1988; Lorez et al., 2000) , but some variation is not unexpected because of effects of temperature and synaptic clustering on channel properties (Petrini et al., 2003; Everitt et al., 2004) .
Increases in tonic GABA A currents suggest increases in extracellular GABA during SE
Unlike the mean amplitude of synaptic mIPSCs, the mean amplitude of tonic currents increased by 240% in slices from SE rats (Ϫ73.3 Ϯ 68.2 pA in SE vs Ϫ30.4 Ϯ 20.4 pA in controls; p Ͻ 0.001; n ϭ 26) (Fig. 5A) . We also note an increase of baseline holding current SD before application of the GABA A receptor antagonist SR95531 (7.8 Ϯ 3.4 pA for SE and 4.9 Ϯ 1.8 pA for controls; p Ͻ 0.001). In vitro measurement of a difference with SE depended on the presence of a GABA uptake inhibitor (10 M NO711) in the perfusate, presumably because blocking GABA uptake helps preserve the extracellular changes generated by SE in vivo for detection in vitro. Recordings done within 2 h of killing show an even larger difference for tonic current amplitude (Ϫ130.0 Ϯ 73.6 pA in SE vs Ϫ44.8 Ϯ 19.2 pA in controls; p Ͻ 0.05; n ϭ 9) and baseline SD (11.05 Ϯ 2.31 pA for SE and 6.10 Ϯ 1.53 pA for controls; p Ͻ 0.001), whereas cells patched beyond 2 h after killing show no significant difference in tonic current amplitude (Ϫ32.7 Ϯ 17.9 pA for SE vs Ϫ24.6 Ϯ 18.7 pA in controls; (Fig. 4) . p Ͼ 0.05; n ϭ 17), suggesting normalization during slice incubation (supplemental Fig. 2 B, available at www.jneurosci.org as supplemental material).
Previous studies suggest that extrasynaptic ␦ subunitcontaining GABA A receptors underlie tonic currents in cerebellar and dentate gyrus granule cells (Nusser et al., 1998b; Stell et al., 2003) and that GABA release increases during SE (Walton et al., 1990; Wasterlain et al., 1993) . To assess the role of extracellular [GABA] on the tonic current difference with SE, a modelgenerated dose-response curve was optimized to fit the mean and variance of tonic currents from both control and SE cells (Fig.  5B) . Optimization of the variables of Equation 3 for the individual tonic receptor current and numbers per cell (see Materials and Methods, Computer modeling) determine the solid curve. GABA A receptor kinetic parameters (Table 1 , column 4) subsequently were optimized to determine tonic current means and SDs for 1 M increments of extracellular [GABA] , using tonic currents measured from controls with known perfusate [GABA] to constrain the optimization. Because both control and SE cells align the dose-response curve, the difference between the two populations predominantly can be accounted for by micromolar increases in extracellular [GABA] during SE. A slight increase in the number of extrasynaptic receptors and/or receptor current during SE cannot be excluded, but additional support for the interpretation that an increase in extracellular [GABA] is responsible for the larger tonic currents was provided by experiments that perfused SE and control slices with 100 M saturating [GABA] in the presence of 10 M NO711 to reduce GABA reuptake. Although GABA exposure would be expected to accentuate differences because of changes in receptor number or channel conductance, saturating the receptors with high [GABA] should overwhelm any differences resulting from endogenous increases in extracellular [GABA] with SE. In the presence of 100 M [GABA], no significant difference in tonic currents between control and SE slices was observed (Ϫ235 Ϯ 83 pA for SE vs Ϫ271 Ϯ 79 pA for controls; n ϭ 28).
The GABA A receptor kinetic parameters optimized for the Table 1 ).
tonic currents and phasic (synaptic) mIPSCs (Table 1) were applied to model simulations to generate dose-response curves and step responses (Fig. 5C ). Note the lower EC 50 value predicted for tonic current receptors (0.4 M) compared with synaptic receptors (25 M), consistent with the greater binding and lower unbinding rate of GABA for tonic current receptors (as indicated by the increase of K on and decrease of K off ) (Table 1) (Stell and Mody, 2002) . In addition, fast desensitization with step responses is predicted for synaptic receptors, whereas slow desensitization is noted for tonic receptors (Fig. 5C) . The model responses to GABA steps and the EC 50 values of our model dose-response curves for synaptic (or tonic) receptors correlate well with results for in vitro expression systems using ␥2 (or ␦)-containing subunits, respectively (Saxena and Macdonald, 1996; Haas and Macdonald, 1999; Brown et al., 2002) .
GABA exposure may contribute to diminished synaptic GABA A inhibition and loss of paired-pulse inhibition
We have shown in vivo that brief (1-3 min) seizure-like stimulation of the perforant path causes a lasting (43 Ϯ 15 min) loss of paired-pulse inhibition (PPI) in the dentate gyrus (Naylor, 2002) . To assess how SE could affect PPI, the model for individual synapses was adapted to fit perforant path-evoked IPSCs of dentate granule cells in slices (Fig. 6 A) . Adjustable parameters were for the number of inhibitory synapses and linear filtering constants, whereas synaptic parameters were defined from previous mIPSC fits and treated as fixed constants for this stage of the modeling (see Materials and Methods, Computer modeling). After this optimization, delivery of paired pulses to the evoked model using either the control or SE parameter values (Table 1) shows a loss of PPI with the latter (Fig. 6 B) . The model-predicted PPI as assessed by paired-pulse ratios (P2/P1) is reduced 35% with SE. A similar loss of PPI (attributed to effects at postsynaptic GABA A receptors) has been observed with evoked IPSCs using an in vitro representation of the perforant path stimulation model of SE (Naylor and Wasterlain, 2005) . Although paired-pulse responses can be influenced by many factors that are not accounted for by this model (e.g., presynaptic probability of release), our results suggest that diminished postsynaptic GABA A receptor inhibition is an important and early element in the loss of PPI. The primary variable responsible for the model-predicted loss of PPI using the SE parameters is the increase in extracellular [GABA] to 5 M, suggesting that increased [GABA] at the synapse may occur rapidly during SE [because loss of PPI is observed within minutes (Naylor, 2002) ]. If this is correct, one would predict that exposure of hippocampal slices to elevated [GABA] in the perfusate would mimic the changes in synaptic and in tonic currents observed during SE. Indeed, a 45% decrease in mIPSC amplitude (Ϫ28.0 Ϯ 6.7 pA after exposure vs Ϫ51.3 Ϯ 15.2 pA before; p Ͻ 0.001; n ϭ 13) and a tonic current increase (Fig. 5B ) are noted within 20 min when control slices are exposed to perfusates with 3 M GABA (with the GABA uptake inhibitor NO711), mimicking many effects of SE.
Discussion
After 1 h of SE, we estimate that dentate granule cells have a 50% decrease in the number of physiologically active GABA A receptors per granule cell synapse and a 69 and 76% reduction, respectively, of the number of ␤2/␤3 and ␥2 subunit-like immunoreactivity in the vicinity of the presynaptic marker synaptophysin. Normalization of synaptic physiology with incubation after slice preparation (which arrests seizures) may explain the lower estimate obtained from mIPSC analysis compared with immunocytochemistry (supplemental Fig. 2 A, available at www.jneurosci. org as supplemental material). A commensurate increase in ␤2/␤3 and ␥2 subunit-LI in the cytoplasm suggests that the subunits relocate to the cell interior during SE, possibly through endocytosis or decreased recycling to the surface. This loss of physiologically active receptors is mimicked by a 20 min exposure of slices to GABA, suggesting that an increase in GABA release with seizure activity may be a contributing factor. The reduction of GABA A synaptic receptors may characterize the key transition in which the potent intrinsic mechanisms that usually stop seizures fail and SE becomes self-sustaining (Mazarati et al., 1998a) . Of note, the time course for the loss of benzodiazepine responsiveness, which fails between 10 and 45 min of SE (Kapur and Macdonald, 1997) , parallels the emergence of self-sustaining SE in both the perforant-path stimulation (Mazarati et al., 1998a) and lithium-pilocarpine models (L. Suchomelova and C. Wasterlain, personal communication) . Furthermore, a loss of inhibition exceeding 30%, as assessed by paired-pulse inhibition, is predicted to result in spontaneous seizures , and the seizures also cause a loss of paired-pulse inhibition ). Because our model results suggest a 35% loss of paired-pulse inhibition after 1 h of SE, a threshold may be exceeded for generating spontaneous seizures that, in turn, may sustain the loss of inhibition.
The differential effect of SE on the amplitude of phasic (mIPSC) compared with tonic currents may be explained by differences in GABA A receptor subunit compositions that underlie each current type. GABA A receptors containing the ␥2 subunit are associated with sensitivity to benzodiazepines (Saxena and Macdonald, 1996) and markedly desensitize to GABA exposure (Haas and Macdonald, 1999) . The ␥2 subunit in receptors contained at synapses associates with the synaptic clustering molecule gephyrin (Essrich et al., 1998; Nusser et al., 1998b) , interacts with the adaptin AP2 complex for clathrin-dependent endocytosis (Connolly et al., 1999; Kittler et al., 2000) , and has several consensus sequences for phosphorylation at serine-threonine and tyrosine sites that affect receptor kinetics, desensitization, and/or receptor internalization (Krishek et al., 1994; Martina et al., 1996; Wan et al., 1997; Amico et al., 1998; Connolly et al., 1999; Kittler and Moss, 2003; Wang et al., 2003a,b) . Conversely, extrasynaptic receptors that contain the ␦ subunit (Nusser et al., 1998b) show little desensitization or benzodiazepine sensitivity (Saxena and Macdonald, 1996; Haas and Macdonald, 1999; Brown et al., 2002) .
Our model results suggest that a 5-10 M increase in extracellular [GABA] during SE is sufficient to explain the increase of extrasynaptic tonic currents that we observed, whereas increased [GABA] at synapses can result in desensitization and internalization of postsynaptic GABA A receptors. Supporting this, SE increases GABA release (Walton et al., 1990; Wasterlain et al., 1993) , consistent with increases in cell-firing elevating GABA A tonic currents (Brickley et al., 1996) , micromolar levels of extracellular [GABA] can desensitize GABA A receptors (Overstreet et al., 2000) , and increased agonist exposure contributes to endocytosis of GABA A receptors (Barnes, 1996) . Furthermore, 5 M GABA in the perfusate causes mIPSC amplitude decreases and tonic current increases (Overstreet and Westbrook, 2001) , similar to those that we found for SE. It is difficult to assess how much an increase in extracellular GABA during SE can increase GABA tonic currents in vivo (and counterbalance the loss of synaptic inhibition), because our measurements of tonic currents reflect slice conditions in the presence of GABA uptake inhibitors.
It is unlikely that the decrease in synaptic mIPSC and increase in tonic current amplitudes result from a shift of receptors from synaptic to extrasynaptic locations. Although lateral diffusion of GABA A receptors might explain the decreased colocalization of receptor subunits at the synapse, it would not explain the increased immunoreactivity in the cytoplasm for both ␤2/␤3 and ␥2 subunits. In addition, because the synaptic receptors containing the ␥2 subunit rapidly desensitize (Haas and Macdonald, 1999; Overstreet et al., 2000) , movement of synaptic receptors to extrasynaptic sites should not account for the increased tonic currents, and our model results suggest that the increased tonic currents with SE result from elevated extracellular [GABA] rather than an increase in extrasynaptic receptor number or single channel current. Additional experiments using antibodies to ␦ subunits to test these interpretations are in progress.
Signal transduction pathways activated during SE also have important modulatory effects on GABA A receptors, affecting both phosphorylation state and internalization. For example, calcineurin activation causes ␥2 subunit dephosphorylation and a decrease of functional postsynaptic GABA A receptors with synaptic depression (Wang et al., 2003a) , and calcineurin activity is potentiated during SE (Kurz et al., 2001 ). We found an increase in NMDA currents during SE (D.E. Naylor, H. Liu, and C.G. Wasterlain, unpublished observations), which could facilitate calcium potentiation of such a mechanism. Loss of GABAergic inhibition in some models of epilepsy has been attributed to NMDA receptor activation (Kapur and Lothman, 1990) . Although our prediction of longer exposure of receptors to cleft GABA during SE can explain the prolongation of mIPSC decay, calcineurin can prolong IPSCs as well (Jones and Westbrook, 1997) . Protein kinase C also is activated during seizures (Osonoe et al., 1994) , and the ␤ subunits of GABA A receptors have consensus sequences for phosphorylation by protein kinase C (Connolly et al., 1999; Kittler and Moss, 2003) and other kinases/ phosphatases that affect delivery of GABA A receptors to the cell surface (Wan et al., 1997; Wang et al., 2003a,b) . In addition to desensitization and/or phosphorylation, variation in GABA A subunit compositions affects mIPSC kinetics and seizure threshold (McIntyre et al., 2002) , suggesting that selective subunit internalization could shape mIPSC kinetics as well.
It is likely that multiple mechanisms contribute to the mIPSC amplitude and kinetic changes in hippocampal granule cells during SE. Because the dentate gyrus is an important gatekeeper for the propagation of epileptiform activity, the changes we observe in granule cells should have significant effects on the spread of seizures within and outside the hippocampus (Heinemann et al., 1992) . Our results suggest that SE-induced changes at GABA A synapses can account for loss of paired-pulse inhibition in the dentate gyrus, providing a basis for early breakdown of its gatekeeper function with SE. We also found that CA1 pyramidal cells and hilar neurons display GABA A receptor subunit internalization, suggesting more distributed effects on GABAergic inhibition in the hippocampus during SE.
Relocation of GABA A receptors from synapses to the cell interior helps explain receptor losses observed physiologically, and the resulting decrease in the availability of receptors for ligand binding may be responsible for the time-dependent, progressive decrease in efficacy of benzodiazepines during SE in vivo (Walton and Treiman, 1988; Mazarati et al., 1998b) and for the reduction in benzodiazepine potency in vitro in dissociated neurons isolated from animals in SE (Kapur and Macdonald, 1997) . It also could account for the observation that, in humans, benzodiazepines are effective in early SE but not in late SE (Treiman et al., 1998) . After SE, we found that mIPSCs of granule cells do respond to high-diazepam concentrations, but the response is insufficient to restore synaptic inhibition to control levels (compatible with a reduced number of synaptic GABA A receptors).
Several clinical implications have emerged. First, the functional loss of GABA A receptors resulting from subunit trafficking may explain the time-dependent development of pharmacoresistance to GABAergic agents in SE and represents a new mechanism of pharmacoresistance that might have implications beyond SE (de Krom et al., 1995; Ali and Olsen, 2001; Fitzek et al., 2001; Kumar et al., 2003) . Our findings emphasize the importance of recognizing a crucial time window for delivery of GABAenhancing medications during SE, stress the role of additional pharmacotherapies for effective treatment (including those directed against glutamatergic excitation), and may explain timedependent relationships for different anticonvulsants (Walton and Treiman, 1991; Jones et al., 2002) . A mechanism is proposed in the acute situation of SE whereby "seizures beget seizures." Persistent cell firing and GABA release during seizures may lead to accumulation of GABA, desensitization and internalization of postsynaptic GABA A receptors with ultimate failure of inhibition, and the emergence of self-sustaining seizures and continu-ation of the vicious cycle of cell firing. Because NMDA activation during SE may contribute to downregulation of GABAergic inhibition (Wang et al., 2003a) , NMDA antagonism may not only oppose excess glutamatergic excitation but enhance inhibition as well. Novel approaches for treatment of SE might include manipulation of the GABA A receptor phosphorylation or desensitization state, prevention of receptor endocytosis with osmotic agents such as mannitol (Heuser and Anderson, 1989) , and management of the intracellular signal pathways for GABA A receptor trafficking. Additional potentiation of tonic currents by modulators such as neurosteroids (Stell et al., 2003) may also be possible.
